Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
IDYA
Stock Latest News
The Fly
Ideaya Biosciences enrolls first patient in IDE397 trial
2d ago
GILD
IDYA
Premium
The Fly
Ideaya Biosciences initiated with an Outperform at Citizens JMP
2d ago
IDYA
Premium
The Fly
Ideaya Biosciences initiated with an Overweight at Barclays
2d ago
IDYA
Premium
Ratings
Hold Rating for IDEAYA Biosciences Amid Favorable Financial Terms and Developmental Risks
2d ago
IDYA
Premium
The Fly
Ideaya Biosciences price target raised to $74 from $72 at JPMorgan
3d ago
IDYA
Premium
The Fly
Ideaya Biosciences submits IDE892 IND application to FDA
3d ago
IDYA
Premium
Ratings
IDEAYA Biosciences: Strategic Partnership with Servier Bolsters Financial Outlook and Validates Darovasertib Potential
3d ago
IDYA
Premium
Ratings
IDEAYA Biosciences: Strategic Partnerships and Financial Strength Underpin Buy Rating
4d ago
IDYA
Premium
Company Announcements
IDEAYA Biosciences Licenses Darovasertib to Servier
4d ago
8K
IDYA
Premium
The Fly
Ideaya Biosciences, Servier announce exclusive darovasertib license agreement
4d ago
IDYA
Premium
Company Announcements
GSK and Ideaya’s Promising Study on Solid Tumors: A Potential Game-Changer?
29d ago
GSK
IDYA
Premium
Ratings
IDEAYA Biosciences: Hold Rating Amid Key Pipeline Developments and Anticipated Clinical Milestones
29d ago
IDYA
Premium
Company Announcements
GSK and Ideaya’s Promising Study on Tumor-Reducing Drug GSK4418959
1M ago
GSK
IDYA
Premium
Company Announcements
IDEAYA Biosciences Reports Q2 2025 Financial Results
1M ago
IDYA
Premium
Ratings
IDEAYA Biosciences: Promising Clinical Data and Strong Financial Health Support Buy Rating
1M ago
IDYA
Premium
Ratings
IDEAYA Biosciences: Promising Catalysts and Late-Stage Developments Fuel Buy Rating
1M ago
IDYA
Premium
The Fly
Ideaya Biosciences reports Q2 EPS (88c), consensus (79c)
1M ago
IDYA
Premium
Company Announcements
Ideaya Biosciences Advances in Ocular Melanoma Treatment with Darovasertib Study
1M ago
IDYA
Premium
The Fly
JPMorgan ups Ideaya target, adds to Analyst Focus List
1M ago
IDYA
Premium
Ratings
IDEAYA Biosciences’ Promising Potential with IDE849: Analyst Charles Zhu’s Buy Rating Ahead of WCLC 2025
1M ago
IDYA
Premium
The Fly
Ideaya Biosciences, Hengrui announce oral presentation at IASLC 2025
2M ago
IDYA
Premium
The Fly
Ideaya Biosciences initiated with a Buy at TD Cowen
2M ago
IDYA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
